BenevolentAI
ben a novel target for data support the rationale for as a novel target for regulates signal transduction by is in derived colon and colonic mucosa samples whilst which makes is down regulated reduced levels of correlate with increased in colonic mucosa is in and its expression inversely correlates to disease severity is well studied in disorders but not in in with zero linkage to demonstrates restricted expression in peripheral tissue reduces the safety liability of targeted inhibition | BenevolentAI
Company
Deck Type
Sector
Industry
Deck date
September 2022
Slide
57 of 74
Similar slides by BenevolentAI
See diffirences between slides (animation)
Results
March 2023
ben a novel target for data support the rationale for as a novel target for regulates signal transduction by is in derived colon and colonic mucosa samples whilst which makes is down regulated reduced levels of correlate with increased in colonic mucosa is in and its expression inversely correlates to disease severity is well studied in disorders but not in in with zero linkage to demonstrates restricted expression in peripheral tissue reduces the safety liability of targeted inhibition degrades differential expression of a and normal low basal expression highest levels in brain low basal soluble levels except in colon and intestine | BenevolentAI
Investor Presentation
October 2022
ben a novel target for data support the rationale for as a novel target for regulates signal transduction by is in derived colon and colonic mucosa samples whilst which makes is down regulated reduced levels of correlate with increased in colonic mucosa is in and its expression inversely correlates to disease severity is well studied in disorders but not in in with zero linkage to demonstrates restricted expression in peripheral tissue reduces the safety liability of targeted inhibition | BenevolentAI
Investor Presentation
June 2022
ben a novel target for | BenevolentAI
SPAC
December 2021
a novel target for data support the rationale for as a novel target for regulates signal transduction by is in derived colon and colonic mucosa samples whilst which makes is down regulated reduced levels of correlate with increased in colonic mucosa is in and its expression inversely correlates to disease severity is well studied in disorders but not in in with zero linkage to was experimentally validated as a novel target using biopsies from pharmacotherapy resistant patients in release from samples reduced with inhibition | BenevolentAI
Related slides by other companies
Kymera
Investor Day
December 2021
novel to drug a new generation of targets | Kymera
DICE Therapeutics
Results
March 2023
confirmed dose dependent target engagement and biological activity | DICE Therapeutics
Absci
Investor Presentation
October 2022
naturalness is also associated with a higher level of expression in cells and lower mutational load | Absci
Other recent decks by BenevolentAI
See all presentations (10 decks)
Results
March 2024
Investor Conference
January 2024
Investor Presentation
May 2023
Results
March 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io